INmune Bio logo

INmune Bio

INMB | NASDAQ
Chart Builder DCF Calculator
$0.95
-$0.10 (-9.52%)
At close: Nov 16, 2026, 4:00 PM ET
$0.95
$0.00 (-0.38%)
After-hours: Nov 16, 2026, 7:30 PM ET
-9.52%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
41
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #493/1021 (Top 48%)

Key Statistics

Market Data

Market Cap $29.3M
1D Range
0.89 1.04
52W Range
0.89 2.51

Valuation (TTM)

PE -1.53
PB 1.62
EV/EBITDA -0.85

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $22.00
Loading financial charts...

Profile

INmune Bio, Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies. Its primary objective is to harness the body's innate immune system to combat various illnesses....

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Feb 4, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$22.00
Upside
+2215.79%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.